Day: November 21, 2019

PHILADELPHIA, PA.,, Nov. 21, 2019 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF), a leading retail software and technology company, announced today that—in partnership with Onyx-Cognivas Pty.—it is launching two privately-led security deployments in South Africa to support community safety initiatives. The state-of-the-art security technology will protect two prominent high-rise residential apartment buildings in the upmarket Sandton area, a high income residential, financial and business suburb of Johannesburg with a population of 225,000. The rollout plan is to deploy this technology across several apartment blocks, a hotel and commercial properties in the precinct—with the objective of deploying a “private Smart City“.In addition, advanced custom sensory applications are planned to...

Venice, Florida, Nov. 21, 2019 (GLOBE NEWSWIRE) — Freedom Boat Club, a division of Brunswick Corporation (NYSE: BC) and the nation’s oldest and largest boat club and premiere boat club franchisor, has just completed the largest franchise conference in company’s 30-year history and its first since being acquired by Brunswick.  The theme of the event, Expanding Horizons, celebrated three decades of success with a recognition of the now more than 200 locations and a strong focus on future growth.  Over the course of four days, franchisees were able to experience some of the newest and most cutting-edge products in the industry while ordering new boats and engaging with other franchisees and members of the Brunswick leadership team including CEO Dave Foulkes and President of Business Acceleration Brenna Preisser among others.“It just...

CAMBRIDGE, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today the enrollment of the last patient in the global Phase 3 STAR clinical study, which is evaluating the investigational gene therapy timrepigene emparvovec (BIIB111/AAV2-REP1) for the treatment of choroideremia (CHM). CHM is a rare, degenerative, X-linked inherited retinal disorder that leads to blindness.“We are excited to advance innovative investigational treatments for inherited retinal disorders that have significant unmet medical need due to the lack of treatment options,” said Alfred Sandrock, Jr., M.D., Ph.D., Executive Vice President, Research and Development, and Chief Medical Officer at Biogen. “Timrepigene emparvovec could be a transformative gene therapy for individuals living with choroideremia who would otherwise face inevitable...

NEW HAVEN, Conn., Nov. 21, 2019 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, announced today that Laurie Smaldone Alsup, M.D., has joined its board of directors. Dr. Smaldone Alsup, who is currently the Chief Scientific Officer and Chief Medical Officer for NDA Group, brings experience leading commercially successful product approvals and global regulatory strategies that have advanced programs through all stages of clinical development.“Laurie has a track record of leading the regulatory approval efforts for dozens of marketed products, increasing patient access to new medicines around the globe,“ said John Houston, Ph.D., President and CEO of Arvinas. “At Arvinas, our mission is to bring innovative new medicines to patients with limited...

TORONTO, Nov. 21, 2019 (GLOBE NEWSWIRE) — Lift & Co. (TSXV: LIFT) (OTCQB: LFCOF), is excited to announce an industry-first cannabis consumer profiling and segmentation tool: Cohesion Segmentation – powered by Nielsen. This solution will bring together industry digital consumer data with Lift & Co.’s knowledge of the Canadian cannabis consumer into a powerful tool for cannabis marketers to understand, segment and target new and existing consumers with great precision.Launched September 2019, Lift & Co.’s Cohesion is a consumer insights platform that draws from millions of cannabis consumer and budtender data points, accumulated through verified reviews, purchase receipts and brand research on the Lift.co and CannSell platforms. Now with Lift & Co.’s unique cannabis consumer profile datasets, brands will...

NEW YORK and TORONTO, Nov. 21, 2019 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the leader in augmented reality for e-commerce and AR learning applications, is pleased to announce that Technivorm Moccamaster, a Dutch manufacturer of premium quality coffee brewers and grinders, has signed a deal for the company’s WebAR e-commerce solution.Nextech continues to scale and sign up new customers for its state of the art end to end AR ecommerce solutions. The company is now able to scale by using its recently announced revolutionary CaptureAR technology, a lightning-fast AR creation tool which uses a cell phone camera to create 3D AR photorealistic objects. Photo realistic ARitized product SKUs are viewed from an e-Commerce product page using augmented reality in a standard web browser,...

Nes Ziona, Israel, Nov. 21, 2019 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (“Enlivex” or the “Company”) (NASDAQ: ENLV) today announced that it has withdrawn its previously announced proposed underwritten public offering of ordinary shares due to market conditions.  The Company currently believes that it is not in the best interest of its shareholders to raise equity capital in the current market environment.  The Company remains well capitalized with cash and cash equivalents, together with short term deposits, of approximately $13.5 million as of September 30, 2019, which the Company believes will be sufficient to fund its current operations through the beginning of the second quarter of 2021.About EnlivexEnlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing....

Please find enclosed the presentation of Golden Ocean Group Limited’s third quarter 2019 results for today’s webcast / conference call at 15:00 CET.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentQ3 2019 Presentation

PETAH TIKVA, Israel, Nov. 21, 2019 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that Gilat achieved the fastest ever modem speeds of 1.2 Gbps total throughput over Telesat’s Phase 1 LEO satellite. This industry milestone demonstrates the potential of high throughput Non-Geostationary Orbit (NGSO) satellite constellations. Gilat’s technology opens opportunities for new telecommunications products and a wider range of customer experiences to markets demanding very high throughputs such as cruise ships, large airplanes, trunking and high-capacity government applications. Additionally, the combination of high throughput provided by Gilat’s innovative technology and the low latency from NGSO creates opportunity...

SALT LAKE CITY, Nov. 21, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the BRACAnalysis® Diagnostic System (i.e., “BRACAnalysis”) to help physicians determine which women with breast cancer have Hereditary Breast and Ovarian Cancer (HBOC) syndrome and qualify for additional medical management. BRACAnalysis is a genetic test that identifies germline mutations in the BRCA1/2 genes.  “We are excited that the MHLW has approved the BRACAnalysis Diagnostic System for HBOC risk assessment in patients with breast cancer,” said Seigo Nakamura, M.D., Ph.D., Professor and Chairman, Department of Surgery, Division of Breast Surgical Oncology and Director, Breast Center of Showa University...